Aspirin and PIK3CA Mutations in Colorectal Cancer

被引：0
|
作者：
Kirstein, M. M. [1 ]
Vogel, A. [1 ]
机构：
[1] Hannover Med Sch, Abt Gastroenterol Hepatol & Endokrinol, D-30625 Hannover, Germany
来源：
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2014年 / 52卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：306 / 307
页数：2
相关论文
共 50 条
  • [1] The Landscape of PIK3CA Mutations in Colorectal Cancer
    Voutsadakis, Ioannis A.
    CLINICAL COLORECTAL CANCER, 2021, 20 (03) : 201 - 215
  • [2] Aspirin for colorectal cancer with PIK3CA mutations: the rising of the oldest targeted therapy?
    Amatu, Alessio
    Bencardino, Katia
    Sartore-Bianchi, Andrea
    Siena, Salvatore
    ANNALS OF TRANSLATIONAL MEDICINE, 2013, 1 (02)
  • [3] Aspirin, PIK3CA Mutation, and Colorectal-Cancer Survival
    Sahin, Ibrahim H.
    Garrett, Christopher
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (03): : 289 - 289
  • [4] PIK3CA in colorectal cancer
    Cathomas, Gieri
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [5] Aspirin Therapy for Colorectal Cancer With PIK3CA Mutation: Simply Complex!
    Fuchs, Charles S.
    Ogino, Shuji
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (34) : 4358 - 4361
  • [6] PIK3CA MUTATIONS PREDICT FOR RESPONSE TO ASPIRIN THERAPY
    不详
    CANCER DISCOVERY, 2012, 2 (12) : 1073 - 1073
  • [7] Aspirin-Induced Chemoprevention and Response Kinetics Are Enhanced by PIK3CA Mutations in Colorectal Cancer Cells
    Zumwalt, Timothy J.
    Wodarz, Dominik
    Komarova, Natalia L.
    Toden, Shusuke
    Turner, Jacob
    Cardenas, Jacob
    Burn, John
    Chan, Andrew T.
    Boland, C. Richard
    Goel, Ajay
    CANCER PREVENTION RESEARCH, 2017, 10 (03) : 208 - 218
  • [8] PIK3Ca mutations in prostate cancer
    Agell, Laia
    Hernandez, Silvia
    de Muga, Silvia
    Lorente, Jose Antonio
    Juanpere, Nuria
    Esgueva, Raquel
    Gelabert, Antoni
    Serrano, Sergi
    Lloreta, Josep
    VIRCHOWS ARCHIV, 2008, 452 : S26 - S27
  • [9] Functional analysis of PIK3CA gene mutations in human colorectal cancer
    Ikenoue, T
    Kanai, F
    Hikiba, Y
    Obata, T
    Tanaka, Y
    Imamura, J
    Ohta, M
    Jazag, A
    Guleng, B
    Tateishi, K
    Asaoka, Y
    Matsumura, M
    Kawabe, T
    Omata, M
    CANCER RESEARCH, 2005, 65 (11) : 4562 - 4567
  • [10] Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin
    Sanja B. Turturro
    Matthew S. Najor
    Carl E. Ruby
    Melody A. Cobleigh
    Abde M. Abukhdeir
    Breast Cancer Research and Treatment, 2016, 156 : 33 - 43
12345